Mainz, Germany

Thomas Wölfel


Average Co-Inventor Count = 7.6

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Thomas Wölfel: Innovator in Cancer Research

Introduction

Thomas Wölfel is a prominent inventor based in Mainz, Germany. He has made significant contributions to the field of cancer research, particularly in the identification and treatment of cellular abnormalities. With a total of 3 patents to his name, Wölfel's work has the potential to impact therapeutic and diagnostic approaches in oncology.

Latest Patents

Wölfel's latest patents include innovative methods for identifying individuals suffering from cellular abnormalities. One notable invention focuses on complexes of human leukocyte antigen molecules and tyrosinase-derived peptides on the surfaces of abnormal cells. This invention has important therapeutic and diagnostic implications. Another patent addresses the identification of these complexes, emphasizing the diagnostic ramifications of this observation.

Career Highlights

Wölfel is associated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research. His work is characterized by a commitment to understanding the complexities of cancer at a cellular level. His inventions aim to provide new avenues for treatment and diagnosis, showcasing his dedication to improving patient outcomes.

Collaborations

Thomas Wölfel has collaborated with notable colleagues in his field, including Vincent Brichard and Aline Van Pel. These partnerships have fostered a collaborative environment that enhances the research and development of innovative cancer therapies.

Conclusion

In summary, Thomas Wölfel is a key figure in cancer research, with a focus on identifying and treating cellular abnormalities. His patents reflect a commitment to advancing medical science and improving the lives of individuals affected by cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…